Enliven Therapeutics ELVN
NASDAQ ELVN
$41.93 +0.11 (+0.26%)
At close: Oct 22, 2026 · 4:00 PM EDT

Enliven Therapeutics (ELVN) EBITDA Margin (2019 - 2026)

Updated

Analysis

Enliven Therapeutics (ELVN) EBITDA Margin (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 32.68%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 49.01%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 6.02%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 33.11%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 46.01%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -124.26%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 39.16%
10 Enliven Therapeutics 2.78 Bn 491.13 Mn - -786.18%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -786.18%
Mar 31, 2026 -662.75%
Dec 31, 2025 -740.62%
Sep 30, 2025 -505.94%
Jun 30, 2025 -876.75%
Mar 31, 2025 -989.33%
Dec 31, 2024 -722.09%
Sep 30, 2024 -703.00%
Jun 30, 2024 -600.20%
Mar 31, 2024 -797.17%
Dec 31, 2023 -672.48%
Sep 30, 2023 -692.12%
Jun 30, 2023 -587.75%
Mar 31, 2023 -965.23%
Dec 31, 2022 -1,649.92%
Sep 30, 2022 -2,861.58%
Jun 30, 2022 -7,058.27%
Mar 31, 2022 336,911.11%
Dec 31, 2021 -19,872.22%
Sep 30, 2021 -45,450.00%
API Access

Enliven Therapeutics EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ELVN&period=max&api_key=YOUR_API_KEY